Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT

Transcode Therapeutics (RNAZ) EBITDA (2021 - 2026)

Updated

Transcode Therapeutics (RNAZ) posted EBITDA of -$6.77 million for Q2 2026, compared with -$4.21 million a year earlier.

Analysis

Transcode Therapeutics (RNAZ) EBITDA (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA at Transcode Therapeutics was -$45.1 million; for FY2025, it came in at -$27.97 million.

  • In prior years, Transcode Therapeutics' EBITDA was -$15.57 million in FY2024, -$19.3 million in FY2023, -$18.54 million in FY2022 and -$6.11 million in FY2021.
  • Quarterly EBITDA has run from a low of -$17.73 million in Q1 2026 to a high of -$2.15 million in Q3 2024 over five years.
  • According to Business Quant data, EBITDA for the three prior quarters was -$17.73 million (Q1 2026), -$16.04 million (Q4 2025) and -$4.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.10 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 8.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 5.09 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.30 Bn
10 Transcode Therapeutics 1.65 Mn 1.65 Mn - -6.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.77 Mn
Mar 31, 2026 -17.73 Mn
Dec 31, 2025 -16.04 Mn
Sep 30, 2025 -4.56 Mn
Jun 30, 2025 -4.21 Mn
Mar 31, 2025 -3.16 Mn
Dec 31, 2024 -5.08 Mn
Sep 30, 2024 -2.15 Mn
Jun 30, 2024 -5.08 Mn
Mar 31, 2024 -3.26 Mn
Dec 31, 2023 -4.07 Mn
Sep 30, 2023 -5.28 Mn
Jun 30, 2023 -5.09 Mn
Mar 31, 2023 -4.86 Mn
Dec 31, 2022 -5.47 Mn
Sep 30, 2022 -4.93 Mn
Jun 30, 2022 -4.68 Mn
Mar 31, 2022 -3.46 Mn
Dec 31, 2021 -2.96 Mn
Sep 30, 2021 -2.35 Mn
API Access

Transcode Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RNAZ&period=max&api_key=YOUR_API_KEY